Search


Current filters:


Start a new search
Add filters:

Use filters to refine the search results.


Results 1-10 of 18 (Search time: 0.002 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2005Phase II study of prolonged ambulatory infusion carboplatin and oral etoposide for patients progressing through hormonal therapy for prostate cancerOlver, I.; Keefe, D.; Myers, M.
2014Dose selection, pharmacokinetics, and pharmacodynamics of BRAF inhibitor dabrafenib (GSK2118436)Falchook, G.; Long, G.; Kurzrock, R.; Kim, K.; Arkenau, H.; Brown, M.; Hamid, O.; Infante, J.; Millward, M.; Pavlick, A.; Chin, M.; O'Day, S.; Blackman, S.; Curtis, C.; Lebowitz, P.; Ma, B.; Ouellet, D.; Kefford, R.
1999Effects of Clozapine for Non-Treatment-Resistant Patients with SchizophreniaGalletly, C.; Clark, C.; McFarlane, A.; Weber, D.
2011Relationship between single nucleotide polymorphisms and haplotypes in DPYD and toxicity and efficacy of capecitabine in advanced colorectal cancerDeenen, M.; Tol, J.; Burylo, A.; Doodeman, V.; de Boer, A.; Vincent, A.; Guchelaar, H.; Smits, P.; Beijnen, J.; Punt, C.; Schellens, J.; Cats, A.
1999Evaluation of the dose-response relationship for intra-nasal oxymetazoline hydrochloride in normal adultsTaverner, D.; Bickford, L.; Shakib, S.; Tonkin, A.
2004Bisphosphonate infusions: patient preference, safety and clinic useChern, B.; Joseph, D.; Joshua, D.; Pittman, K.; Richardson, G.; Schou, M.; Lowe, S.; Copeman, M.; De Abreu Lourenco, R.; Lynch, K.
2007A randomized, comparative study of three doses of AZD0865 and esomeprazole for healing of reflux esophagitisKahrilas, P.; Dent, J.; Lauritsen, K.; Malfertheiner, P.; Denison, H.; Franzen, S.; Hasselgren, G.
2008Pharmacokinetics, efficacy, and tolerability of fentanyl following intranasal versus intravenous administration in adults undergoing third-molar extraction: A randomized, double-blind, double-dummy, two-way, crossover studyChristrup, L.; Foster, D.; Popper, L.; Troen, T.; Upton, R.
2007Response-driven combination therapy with conventional disease-modifying antirheumatic drugs can achieve high response rates in early rheumatoid arthritis with minimal glucocorticoid and nonsteroidal anti-inflammatory drug useProudman, S.; Keen, H.; Stamp, L.; Lee, A.; Goldblatt, F.; Ayres, O.; Rischmueller, M.; James, M.; Hill, C.; Caughey, G.; Cleland, L.
2008Enhanced buprenorphine analgesia with the addition of ultra-low-dose naloxone in healthy subjectsLa Vincente, S.; White, J.; Somogyi, A.; Bochner, F.; Chapleo, C.